Invention Grant
US08148097B2 Screening method for identification of compounds with calcium-independent phospholipase A2β (iPLA2β) modulating activity
有权
用于鉴定不依赖钙的磷脂酶A2＆bgr化合物的筛选方法 （iPLA2＆bgr）调节活性
- Patent Title: Screening method for identification of compounds with calcium-independent phospholipase A2β (iPLA2β) modulating activity
- Patent Title (中): 用于鉴定不依赖钙的磷脂酶A2＆bgr化合物的筛选方法 （iPLA2＆bgr）调节活性
-
Application No.: US12269515Application Date: 2008-11-12
-
Publication No.: US08148097B2Publication Date: 2012-04-03
- Inventor: Richard W. Gross , Christopher Jenkins
- Applicant: Richard W. Gross , Christopher Jenkins
- Applicant Address: US MO St. Louis
- Assignee: Washington University
- Current Assignee: Washington University
- Current Assignee Address: US MO St. Louis
- Agency: Armstrong Teasdale LLP
- Main IPC: C12Q1/34
- IPC: C12Q1/34
Abstract:
An in vitro screening method for identifying a compound with iPLA2β modulating activity.
Public/Granted literature
Information query
